Extra-capsular Parotid Tumor
Dissection
Sathyakrishna B.R.1,
Rajaput S.S. 2
1Dr B. R. Sathyakrishna, Unit head Department of Surgery, 2Santosh Singh
Rajaput, PG student, Department of Surgery; both authors are affilaited
with St Martha Hospital, Bangalore, Karnataka, India.
Address for
correspondence: Dr B. R. Sathyakrishna, Email:
dr.brsk@gmail.com
Abstract
Parotid tumors are one of the common conditions in surgical practice
and gold standard procedure for benign tumors of parotid
being superficial parotidectomy but with risk of complications like
facial nerve injury,whereas, in extra-capsular dissection of parotid,
surgeon performs a careful dissection of the tumor and spares the
handling of facial nerve thereby minimizing chances of facial nerve
injury. We present here a case of benign parotid tumor operated by
extra-capsular dissection.
Keywords:
Parotid gland, Extra-capsular dissection, Facial nerve palsy
Manuscript received: 24th
June 2016, Reviewed:
4th July 2016
Author Corrected:
14th July 2016, Accepted
for Publication: 26th July 2016
Introduction
Parotid gland neoplasm comprises 3% of all head and neck tumors, 80% of
these are benign, 65% are Pleomorphic adenoma and the other 25% are
Warthin’s tumor. Evolution of parotid surgery begins with
enucleation of tumor leaving the capsule in situ, with a high
recurrence rate. Minimizing damage to the facial nerve is one of the
primary objectives of parotid surgery and has encouraged the
development of alternative surgical techniques, including limited
superficial parotidectomy and extra-capsular dissection [1].
Enucleation was first described by Senn in 1895 as the surgical
technique of choice; tumor removal was incomplete, as there was tissue
left behin [2].
In 1940, Janes [3] published article on salivary gland tumor surgery by
parotidectomy with dissection and preservation of the main trunk and
branches of the facial nerve. In this procedure, tumor along with the
superficial lobe was removed. Even though the recurrence rate had
decreased significantly, facial nerve damage was still a risk. Several
changes to this technique have been published over the past 60 years,
yet superficial parotidectomy is still regarded as the gold standard
treatment for Pleomorphic Adenoma.
Anderson in 1975 described Extra-capsular dissection of parotid tumors
in which, a very close and careful dissection of the tumor capsule was
performed while preserving the nerve [4]. Modified Blair incision used
for ECD, surgeon performs careful blunt dissection of tumor by way of
cruciate incision over the tumor, the tumor is then removed along with
its capsule with 2-3 mm rim of normal parotid parenchyma,but without
identification of the facial nerve.
Case
Report
76 years old lady presented to the outpatient department with swelling
in the right parotid region since one year, gradually increasing in
size, not associated with pain, patient is a known hypertensive since 6
years. General physical examination was unremarkable. Local examination
5x5cm swelling noted arising from right parotid gland, firm in
consistency, mobile, oral cavity examination - normal, no cervical
lymphadenopathy.
Routine blood tests were normal, MRI neck (Fig 1) showed well
encapsulated parotid swelling confined to superficial lobe, FNAC showed
benign cystic lesion right parotid. Patient underwent Extra-capsular
dissection (Fig 2-4) under General Anesthesia, intraoperative finding
being well encapsulated tumor of size 5x5 cm, cystic consistency.
Post-operative period uneventful and histopathology being features are
of Warthin’s tumor.(Fig 5)
Fig-1: MRI
showing well encapsulated parotid
tumor Fig-2:
Modified blair incision
Fig-3:
Parotid tumor after raising flap
Fig-4: Tumor specimen
Fig-5: Histopathology
Warthin’s tumor
Discussion
Benign parotid tumor is one of the common condition and treatment being
surgical removal. Three aspects are of importance in treating this
condition, first - the surgical technique, second -post operative
complications and third - chances of recurrence of tumor.
Surgical technique differs from parotidectomy where facial nerve is
identified and dissection done whereas in ECD facial nerve is not
identified, only extra-capsular dissection done.
The rate of temporary postoperative paresis of the facial nerve is
reported as 15% to 25% after superficial parotidectomy and 20% to 50%
after total parotidectomy, whereas the rate of permanent facial nerve
paresis is reported as 5% to 10% [5-9]. On the other hand, there is
evidence in the literature to suggest that the risk of temporary or
permanent facial nerve paresis is significantly less after
extra-capsular dissection than after superficial or total parotidectomy
[5-7].
The tumor for which ECD is ideally suited is the one that is well
defined, mobile, approximately 4 cm in diameter, and lies in the
superficial lobe of the parotid gland.Point against the technique is
the chances of recurrence. Extra-capsular dissection and partial
parotidectomy supposedly have a higher recurrence rate than the other
techniques commonly postulated [5-7]. But recent studies showed the
recurrence rate reported with extra-capsular dissection is similar to
that reported with superficial and total parotidectomy, that
is 0% to 5%[8-10]
Conclusion
We conclude that for a single, unilateral, tumor located in superficial
lobe of parotid gland extra-capsular dissection as a surgical procedure
of choice, can be implemented as an effective alternative to
superficial parotidectomy with reduced operative time and low morbidity.
Funding:
Nil, Conflict of
interest: None initiated
Permission from IRB:
Yes
References
1. Snow G. The surgical approaches to the treatment of parotid
pleomorphic adenomas Controversies in the Management of Salivary Gland
Disease 2001 Oxford, Oxford University Press; 2001, 57–66 .In
McGurk M, Renehan AG (eds) pp.
2. Senn N. The pathology and surgical treatment of tumors.
Philadelphia,PA: W.B. Saunders; 1895.
3. Janes RM. The Treatment of Tumours of the
Salivary Glands by Radical Excision. Can Med Assoc J. 1940
Dec;43(6):554-9. [PubMed]
4. Anderson, R. Benign mixed tumours of the
parotid gland. in: R.G. Chambers, A.M.P. Janssen de Limpens, D.A.
Jaques, R.T. Routledge (Eds.) Cancer of the Head and Neck: Proceedings
of an International Symposium, Montreux, Switzerland, April 2-4, 1975.
International Congress Series, No. 365. Excerpta Medica, Amsterdam, The
Netherlands; 1975:1555–58.
5. Rehberg E, Schroeder HG, Kleinsasser O. Surgery in benign parotid
tumors: individually adapted or standardized radical interventions [in
German]? Laryngorhinootologie 1998;77:283–8. [PubMed]
6. Zernial O, Springer IN, Warnke P, Härle F, Risick C,
Wiltfang J. Long-term recurrence rate of pleomorphic adenoma and
postoperative facial nerve paresis (in parotid surgery). J
Craniomaxillofac Surg. 2007 Apr;35(3):189-92. Epub 2007 Jun 18.
7. Prichard AJ, Barton RP, Narula AA.
Complications of superficial parotidectomy versus extracapsular
lumpectomy in the treatment of benign parotid lesions. J R Coll Surg
Edinb. 1992 Jun;37(3):155-8.
8. McGurk M, Renehan A, Gleave EN, Hancock BD.
Clinical significance of the tumour capsule in the treatment of parotid
pleomorphic adenomas. Br J Surg. 1996 Dec;83(12):1747-9. [PubMed]
9. Witt RL. The significance of the margin in
parotid surgery for pleomorphic adenoma. Laryngoscope. 2002
Dec;112(12):2141-54.
10. Guntinas-Lichius O, Klussmann JP, Wittekindt
C, Stennert E. Parotidectomy for benign parotid disease at a university
teaching hospital: outcome of 963 operations. Laryngoscope 2006 Apr
116(4) :534–40.
How to cite this article?
Sathyakrishna B. R, Rajaput S. S. Extra-capsular Parotid Tumor
Dissection. Int J Med Res Rev
2016;4(8):1307-1309.doi:10.17511/ijmrr.2016.i08.04.